ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 45 filers reported holding ATRECA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $10,819 | -60.2% | 11,040 | -53.7% | 0.00% | – |
Q1 2023 | $27,210 | -68.7% | 23,868 | -78.0% | 0.00% | – |
Q4 2022 | $87,036 | -62.0% | 108,713 | -25.7% | 0.00% | – |
Q3 2022 | $229,000 | -19.9% | 146,323 | -8.4% | 0.00% | – |
Q2 2022 | $286,000 | -44.1% | 159,670 | -1.2% | 0.00% | – |
Q1 2022 | $512,000 | -12.3% | 161,567 | -16.1% | 0.00% | – |
Q4 2021 | $584,000 | -63.2% | 192,631 | -24.3% | 0.00% | – |
Q3 2021 | $1,585,000 | -74.8% | 254,397 | -65.5% | 0.00% | -100.0% |
Q2 2021 | $6,280,000 | -21.1% | 737,088 | +41.9% | 0.00% | -50.0% |
Q1 2021 | $7,964,000 | -23.4% | 519,508 | -19.3% | 0.00% | -33.3% |
Q4 2020 | $10,401,000 | +29.0% | 644,045 | +11.6% | 0.00% | +50.0% |
Q3 2020 | $8,061,000 | +210.0% | 577,065 | +372.2% | 0.00% | +100.0% |
Q2 2020 | $2,600,000 | -42.1% | 122,201 | -55.0% | 0.00% | -50.0% |
Q1 2020 | $4,492,000 | +69.8% | 271,380 | +58.6% | 0.00% | +100.0% |
Q4 2019 | $2,646,000 | +135.6% | 171,072 | +187.2% | 0.00% | 0.0% |
Q2 2019 | $1,123,000 | – | 59,565 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
CM Management, LLC | 249,282 | $391,000 | 0.44% |
Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |